CEL Sci Corp
CVMNYSECIK 725363HealthcareFiscal year ends Sep 30
Reports and events: 306 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-05-0220:39 ET | 8-K | 8.01 Other events | 0001654954-23-005645 |
| 2023-05-0120:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-005494 |
| 2023-04-1914:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-004924 |
| 2023-04-1014:00 ET | DEF 14A | Proxy statementPeriod 2023-05-23 | 0001654954-23-004527 |
| 2023-03-0915:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-002577 |
| 2023-02-1421:16 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001654954-23-001725 |
| 2022-12-2721:15 ET | 10-K | Annual reportPeriod 2022-09-30 | 0001654954-22-016959 |
| 2022-09-1315:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-22-012408 |
| 2022-08-2213:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-22-011627 |
| 2022-08-1220:17 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001654954-22-011196 |
| 2022-08-0820:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-22-010767 |
| 2022-06-1321:02 ET | 8-K | 5.07 Shareholder vote results | 0001654954-22-008281 |
| 2022-05-1320:16 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001654954-22-006762 |
| 2022-04-2920:06 ET | DEF 14A | Proxy statementPeriod 2022-06-13 | 0001654954-22-005663 |
| 2022-02-1121:16 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001654954-22-001491 |
| 2021-12-2121:33 ET | 10-K | Annual reportPeriod 2021-09-30 | 0001654954-21-013417 |
| 2021-08-1320:17 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001654954-21-008919 |
| 2021-07-0719:24 ET | 8-K | 8.01 Other events | 0001654954-21-007693 |
| 2021-07-0221:43 ET | 8-K | 5.07 Shareholder vote results | 0001654954-21-007536 |
| 2021-06-2912:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-21-007358 |
| 2021-06-2820:34 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001004878-21-000049 |
| 2021-06-0920:09 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-21-006720 |
| 2021-05-1815:00 ET | DEF 14A | Proxy statementPeriod 2021-07-01 | 0001654954-21-005944 |
| 2021-05-1720:11 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001654954-21-005882 |
| 2021-02-1221:16 ET | 10-Q | Quarterly reportPeriod 2020-12-31 | 0001654954-21-001609 |
| 2020-12-3122:36 ET | 10-Q/A | Quarterly report, amendedPeriod 2020-06-30 | 0001654954-20-014038 |
| 2020-12-3022:17 ET | 10-Q/A | Quarterly report, amendedPeriod 2020-03-31 | 0001654954-20-014034 |
| 2020-12-3022:16 ET | 10-Q/A | Quarterly report, amendedPeriod 2019-12-31 | 0001654954-20-014033 |
| 2020-12-2922:01 ET | 10-K | Annual reportPeriod 2020-09-30 | 0001654954-20-013975 |
| 2020-12-2922:00 ET | 8-K | 4.02 Non-reliance on financial statements | 0001654954-20-013974 |
| 2020-12-0922:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-20-013326 |
| 2020-12-0823:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-20-013264 |
| 2020-10-3020:17 ET | 8-K | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001654954-20-011660 |
| 2020-08-1101:01 ET | 10-Q/A | Quarterly report, amendedPeriod 2020-06-30 | 0001654954-20-008746 |
| 2020-08-1021:25 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001654954-20-008732 |
| 2020-07-0221:01 ET | S-1 | Registration statement | 0001654954-20-007323 |
| 2020-07-0120:09 ET | 8-K | 3.02 Unregistered sale of equity | 0001654954-20-007228 |
| 2020-05-2621:22 ET | 8-K | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001654954-20-005978 |
| 2020-05-0821:02 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001654954-20-005098 |
| 2020-04-1720:16 ET | 8-K | 5.07 Shareholder vote results | 0001654954-20-004205 |
| 2020-04-0921:04 ET | S-1 | Registration statement | 0001654954-20-003921 |
| 2020-03-2421:17 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-20-003125 |
| 2020-03-0422:20 ET | DEF 14A | Proxy statementPeriod 2020-04-17 | 0001654954-20-002252 |
| 2020-02-2022:18 ET | S-1/A | Registration statement, amended | 0001654954-20-001782 |
| 2020-02-2017:07 ET | 8-K | 5.03 Amendment to articles or bylaws | 0001004878-20-000021 |
| 2020-02-1023:01 ET | 10-Q | Quarterly reportPeriod 2019-12-31 | 0001654954-20-001249 |
| 2019-12-2613:03 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-19-014199 |
| 2019-12-2312:33 ET | 10-K/A | Annual report, amendedPeriod 2019-09-30 | 0001654954-19-014164 |
| 2019-12-2312:30 ET | 8-K | 4.02 Non-reliance on financial statements | 0001654954-19-014163 |
| 2019-12-1621:20 ET | 10-K | Annual reportPeriod 2019-09-30 | 0001654954-19-013971 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.